TVM Capital Life Science Announces Substantially Oversubscribe...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MUNICH and MONTREAL, Oct. 27, 2020 /PRNewswire-AsiaNet/ -- - The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates- In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies a...
Authors: LATEST ASIANET NEWS RELEASES